Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Finasteride's link to depression is questionable due to study flaws and potential bias.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

There's not enough data on finasteride's sexual side effects.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Syphilis can mimic other diseases, making diagnosis challenging, but proper testing and treatment are effective.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Low PON1 levels may indicate and predict the severity of hair loss.

Erectile dysfunction is linked to hormone imbalances and vascular health, requiring personalized treatment approaches.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Finasteride can cause skin rash.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Dutasteride reduces DHT more effectively than finasteride.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The procedure involving seminal vesiculoscopy, TURED, and balloon dilation effectively treated a man's hematospermia and improved his dysorgasmia.

Finasteride can treat prostatic haematuria, but its use is controversial.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.